Infliximab, a TNF-α monoclonal antibody (mAb), is frequently used in the treatment of TNF-α-driven autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease (8). The gene discussed is TNF; the disease is autoimmune disease.